Clinical Trials Logo

Metastatic Biliary Tract Cancer clinical trials

View clinical trials related to Metastatic Biliary Tract Cancer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03524508 Completed - Clinical trials for Metastatic Biliary Tract Cancer

Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer

Start date: September 4, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of combination of fluorouracil/folinic acid and liposomal irinotecan(Onivyde) compared with fluoruracil/folinic acid in patients with metastatic biliary tract cancer which progressed on 1st line gemcitabine/cisplatin.

NCT ID: NCT02866383 Completed - Clinical trials for Metastatic Pancreatic Cancer

Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients

CheckPAC
Start date: November 2016
Phase: Phase 2
Study type: Interventional

This is a prospective, randomized, open-label phase 2 study in patients with metastatic PC or BTC refractory or intolerant to at least one line of prior systemic chemotherapy with gemcitabine or platinum-containing regimens to determine the efficacy and safety of nivolumab or nivolumab plus ipilimumab administered concurrently with high dose RT. Patients with metastatic PC or BTC who are feasible candidates for radiation and biopsy of primary and/or metastatic lesions will be included.